Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Strayer
R Henry

Showing results (1031-1040 of 1,212) with videos related to

Pageof 122
Sort By:
Archives of Pathology & Laboratory Medicine|January 16, 2010
Do liquid-based preparations of urinary cytology perform differently than classically prepared cases? Observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic CytologyRodolfo Laucirica, Joel S Bentz, Rhona J Souers, et al.
Gastrointestinal Endoscopy|April 28, 2016
Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intentFerga C Gleeson, Sarah E Kerr, Benjamin R Kipp, et al.
Clinical Science (London, England : 1979)|August 25, 2011
Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucoseTodd S Perlstein, Robert R Henry, Kieren J Mather, et al.
Diabetes, Obesity & Metabolism|December 29, 2017
Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trialJeremy Pettus, Dominic Reeds, Tricia S Cavaiola, et al.
Diabetes, Obesity & Metabolism|September 15, 2017
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trialLawrence A Leiter, Bertrand Cariou, Dirk Müller-Wieland, et al.
Diabetes, Obesity & Metabolism|February 14, 2018
Alirocumab vs usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trialKausik K Ray, Lawrence A Leiter, Dirk Müller-Wieland, et al.
Cardiovascular Diabetology|May 27, 2017
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular riskDirk Müller-Wieland, Lawrence A Leiter, Bertrand Cariou, et al.
Health Promotion International|February 14, 2021
Use of Korean dramas to facilitate precision mental health understanding and discussion for Asian AmericansVan My Ta Park, Cate Jongkyung Park, Charles Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2020
Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell diseaseEric R Henry, Troy Cellmer, Emily B Dunkelberger, et al.
Metabolism: Clinical and Experimental|October 8, 2017
Circulating ApoJ is closely associated with insulin resistance in human subjectsJi A Seo, Min-Cheol Kang, Theodore P Ciaraldi, et al.
Pageof 122

Showing results (1031-1040 of 1,212) with videos related to

Sort By:
Pageof 122
Archives of Pathology & Laboratory Medicine|January 16, 2010
Do liquid-based preparations of urinary cytology perform differently than classically prepared cases? Observations from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic CytologyRodolfo Laucirica, Joel S Bentz, Rhona J Souers, et al.
Gastrointestinal Endoscopy|April 28, 2016
Molecular cytology genotyping of primary and metastatic GI stromal tumors by using a custom two-gene targeted next-generation sequencing panel with therapeutic intentFerga C Gleeson, Sarah E Kerr, Benjamin R Kipp, et al.
Clinical Science (London, England : 1979)|August 25, 2011
Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucoseTodd S Perlstein, Robert R Henry, Kieren J Mather, et al.
Diabetes, Obesity & Metabolism|December 29, 2017
Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trialJeremy Pettus, Dominic Reeds, Tricia S Cavaiola, et al.
Diabetes, Obesity & Metabolism|September 15, 2017
Efficacy and safety of alirocumab in insulin-treated individuals with type 1 or type 2 diabetes and high cardiovascular risk: The ODYSSEY DM-INSULIN randomized trialLawrence A Leiter, Bertrand Cariou, Dirk Müller-Wieland, et al.
Diabetes, Obesity & Metabolism|February 14, 2018
Alirocumab vs usual lipid-lowering care as add-on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM-DYSLIPIDEMIA randomized trialKausik K Ray, Lawrence A Leiter, Dirk Müller-Wieland, et al.
Cardiovascular Diabetology|May 27, 2017
Design and rationale of the ODYSSEY DM-DYSLIPIDEMIA trial: lipid-lowering efficacy and safety of alirocumab in individuals with type 2 diabetes and mixed dyslipidaemia at high cardiovascular riskDirk Müller-Wieland, Lawrence A Leiter, Bertrand Cariou, et al.
Health Promotion International|February 14, 2021
Use of Korean dramas to facilitate precision mental health understanding and discussion for Asian AmericansVan My Ta Park, Cate Jongkyung Park, Charles Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2020
Allosteric control of hemoglobin S fiber formation by oxygen and its relation to the pathophysiology of sickle cell diseaseEric R Henry, Troy Cellmer, Emily B Dunkelberger, et al.
Metabolism: Clinical and Experimental|October 8, 2017
Circulating ApoJ is closely associated with insulin resistance in human subjectsJi A Seo, Min-Cheol Kang, Theodore P Ciaraldi, et al.
Pageof 122